Published in Lancet on August 17, 2002
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment | NCT03125564
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut (2004) 3.55
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry (2010) 1.61
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut (2006) 1.60
CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol (2004) 1.44
Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ (2005) 1.42
Management of irritable bowel syndrome. Postgrad Med J (2003) 1.40
Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33
Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci (2007) 1.27
Irritable bowel syndrome. Intern Med J (2006) 1.24
Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol (2009) 1.19
Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol (2014) 1.14
Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut (2004) 1.03
Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol (2014) 1.03
[Theories and models of chronicity: on the way to a broader definition of chronic back pain]. Schmerz (2003) 1.01
Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol (2003) 0.95
Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur J Epidemiol (2007) 0.94
Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci (2009) 0.94
Early life factors initiate a 'vicious circle' of affective and gastrointestinal symptoms: A longitudinal study. United European Gastroenterol J (2013) 0.93
Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase. Dig Dis Sci (2010) 0.93
Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care. BMC Public Health (2013) 0.93
Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients. J Gastroenterol (2009) 0.91
Effect of the 5-HT4 receptor and serotonin transporter on visceral hypersensitivity in rats. Braz J Med Biol Res (2012) 0.89
Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil (2013) 0.87
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br J Pharmacol (2004) 0.84
Genes and environment in irritable bowel syndrome: one step forward. Gut (2006) 0.84
More negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS--a case-control study in primary care. BMC Fam Pract (2015) 0.83
Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol (2014) 0.81
The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterol (2011) 0.80
Validity, reliability, and factor analysis of Persian version of quality of life questionnaire for irritable bowel syndrome (IBS-QOL-34). J Res Med Sci (2013) 0.79
Psychological distress and impaired quality of life common among community-dwelling adults with lower gastrointestinal disorders. Dig Dis Sci (2006) 0.78
Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome. World J Gastroenterol (2014) 0.78
Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patients. Int J Clin Exp Med (2014) 0.78
Could gastrointestinal disorders differ in two close but divergent social environments? Int J Health Geogr (2012) 0.76
Pelvic floor complaints in gastroenterology practice: results of a survey in the netherlands. Frontline Gastroenterol (2012) 0.76
Potential of in vivo real-time gastric gas profiling: a pilot evaluation of heat-stress and modulating dietary cinnamon effect in an animal model. Sci Rep (2016) 0.75
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Visceral Hypersensitivity and Altered Colonic Motility in Type 2 Diabetic Rat. J Neurogastroenterol Motil (2015) 0.75
Uncomfortable implications: placebo equivalence in drug management of a functional illness. J Med Ethics (2007) 0.75
Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats. J Gastroenterol (2016) 0.75
Impact of bitter taste on gastric motility. Eur J Gastroenterol Hepatol (2005) 0.96
Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes (2014) 0.95
Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit. Gut (2013) 0.92
Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism. J Physiol (2008) 0.92
Probiotics: an ideal anti-inflammatory treatment for IBS? Gastroenterology (2005) 0.87
Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol (2014) 0.81
New insights into bloating and abdominal distension: is it all outlet obstruction? Am J Gastroenterol (2010) 0.81
Colonic diverticular disease. Clin Evid (2004) 0.79
Searching for the answer to irritable bowel syndrome in the colonic mucosa: SERTainty and unSERTainty. Gastroenterology (2007) 0.78
Colonic diverticular disease. Clin Evid (2002) 0.78
Colonic diverticular disease. Clin Evid (2002) 0.77
Postinfectious functional dyspepsia and postinfectious irritable bowel syndrome: different symptoms but similar risk factors. Gastroenterology (2010) 0.76
Colonic diverticular disease. Clin Evid (2005) 0.76
Colonic diverticular disease. Clin Evid (2003) 0.75
How Gut handles your manuscript. Gut (2005) 0.75
Dysphagia and a skin rash. Gut (2008) 0.75
No cause for alarm in IBS. Practitioner (2002) 0.75
Colonic diverticular disease. Clin Evid (2004) 0.75
A change at the tiller. Gut (2003) 0.75